SHANK2

SH3 and multiple ankyrin repeat domains 2, the group of PDZ domain containing|Sterile alpha motif domain containing|Ankyrin repeat domain containing|MicroRNA protein coding host genes

Basic information

Region (hg38): 11:70467854-71252577

Previous symbols: [ "CORTBP1" ]

Links

ENSG00000162105NCBI:22941OMIM:603290HGNC:14295Uniprot:Q9UPX8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autism, susceptibility to, 17 (Strong), mode of inheritance: AD
  • autism, susceptibility to, 17 (Strong), mode of inheritance: AD
  • complex neurodevelopmental disorder (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Autism, susceptibility to 17ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic20473310

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SHANK2 gene.

  • Autism, susceptibility to, 17 (5 variants)
  • not provided (5 variants)
  • Autism spectrum disorder (2 variants)
  • Rare disease with autism (2 variants)
  • Global developmental delay (1 variants)
  • Neurodevelopmental disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SHANK2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
13
clinvar
58
clinvar
7
clinvar
78
missense
107
clinvar
35
clinvar
7
clinvar
149
nonsense
5
clinvar
2
clinvar
5
clinvar
12
start loss
0
frameshift
9
clinvar
9
clinvar
9
clinvar
27
inframe indel
2
clinvar
1
clinvar
3
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
splice region
4
4
1
9
non coding
20
clinvar
9
clinvar
2
clinvar
31
Total 14 12 157 103 16

Highest pathogenic variant AF is 0.00000657

Variants in SHANK2

This is a list of pathogenic ClinVar variants found in the SHANK2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-70468492-T-A Autism spectrum disorder Likely benign (Jun 14, 2016)305881
11-70468767-G-C Autism spectrum disorder Likely benign (Jun 14, 2016)305882
11-70468840-T-G Autism spectrum disorder Uncertain significance (Jun 14, 2016)305883
11-70468922-G-C Autism spectrum disorder Uncertain significance (Jun 14, 2016)305884
11-70469394-G-C Autism spectrum disorder Uncertain significance (Jun 14, 2016)305885
11-70469623-C-T Autism spectrum disorder Uncertain significance (Jun 14, 2016)305886
11-70469624-A-G Autism spectrum disorder Uncertain significance (Jun 14, 2016)305887
11-70469802-T-C Autism spectrum disorder Uncertain significance (Jun 14, 2016)305888
11-70470286-A-G Autism spectrum disorder Likely benign (Jun 14, 2016)305889
11-70471272-A-C Autism spectrum disorder Likely benign (Jun 14, 2016)305890
11-70471324-A-C Autism spectrum disorder Uncertain significance (Jun 14, 2016)305891
11-70471335-C-CA Autism spectrum disorder Conflicting classifications of pathogenicity (Jan 01, 2023)305892
11-70471847-A-G Autism spectrum disorder Uncertain significance (Jun 14, 2016)305893
11-70472278-G-T Autism spectrum disorder Uncertain significance (Jun 14, 2016)305894
11-70472284-G-A Autism spectrum disorder Uncertain significance (Jun 14, 2016)305895
11-70472890-C-G SHANK2-related disorder Uncertain significance (May 28, 2024)3345015
11-70472925-G-A Uncertain significance (Mar 17, 2014)130305
11-70472944-G-A not specified Uncertain significance (Jun 01, 2015)212172
11-70472947-G-GT Inborn genetic diseases Uncertain significance (Jan 25, 2022)2271782
11-70472966-GGTAA-G not specified Uncertain significance (Sep 13, 2017)1338277
11-70472983-G-A Benign (Sep 01, 2022)2642068
11-70473043-G-A not specified Likely benign (Aug 03, 2017)1336155
11-70473102-T-C not specified Uncertain significance (Jan 31, 2018)1336482
11-70473141-G-A Uncertain significance (Feb 25, 2022)3252847
11-70473145-C-T Likely benign (Jan 01, 2024)3025398

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SHANK2protein_codingprotein_codingENST00000338508 33649663
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
8.43e-71.00125731021257330.00000795
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.329231.14e+30.8070.000080012010
Missense in Polyphen186266.310.698432734
Synonymous-0.2245235171.010.00004273812
Loss of Function5.512678.80.3300.00000459884

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001760.0000176
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Seems to be an adapter protein in the postsynaptic density (PSD) of excitatory synapses that interconnects receptors of the postsynaptic membrane including NMDA-type and metabotropic glutamate receptors, and the actin-based cytoskeleton. May play a role in the structural and functional organization of the dendritic spine and synaptic junction.;
Disease
DISEASE: Autism 17 (AUTS17) [MIM:613436]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:20473310}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Pathway
Glutamatergic synapse - Homo sapiens (human);Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses (Consensus)

Haploinsufficiency Scores

pHI
0.350
hipred
Y
hipred_score
0.682
ghis
0.630

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.788

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Shank2
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype;

Gene ontology

Biological process
synapse assembly;learning;adult behavior;social behavior;brain morphogenesis;synaptic growth at neuromuscular junction;positive regulation of synaptic transmission, glutamatergic;long-term synaptic potentiation;long-term synaptic depression;dendritic spine morphogenesis;positive regulation of dendritic spine development;vocalization behavior;postsynaptic density assembly;regulation of AMPA receptor activity;positive regulation of excitatory postsynaptic potential
Cellular component
photoreceptor outer segment;photoreceptor inner segment;cellular_component;cytosol;neurofilament;plasma membrane;ionotropic glutamate receptor complex;postsynaptic density;apical plasma membrane;cell junction;dendrite;growth cone;brush border membrane;neuron projection;neuronal cell body;dendritic spine;neuron spine;postsynaptic membrane;ciliary membrane
Molecular function
protein binding;SH3 domain binding;receptor signaling complex scaffold activity;GKAP/Homer scaffold activity;ionotropic glutamate receptor binding